Evidence map›Paper›PMID 32945469›Full record

ArticleMolecular medicine reports2020

Increased expression levels of inflammatory cytokines and adhesion molecules in lipopolysaccharide‑induced acute inflammatory apoM‑/‑ mice.

Yuanping Shi, Hongyao Liu, Hong Liu, Yang Yu, Jun Zhang, Yanfei Li, Guanghua Luo, Xiaoying Zhang, Ning Xu

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Revealing the Role of High-Density Lipoprotein in Colorectal Cancer.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Yuanping ShiComprehensive Laboratory, Changzhou Key Laboratory of Individualized Diagnosis and Treatment Associated with High Technology Research, Changzhou, Jiangsu 213003, P.R. China.
Hongyao LiuDepartment of Cardiothoracic Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213003, P.R. China.
Hong LiuDepartment of Cardiothoracic Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213003, P.R. China.
Yang YuComprehensive Laboratory, Changzhou Key Laboratory of Individualized Diagnosis and Treatment Associated with High Technology Research, Changzhou, Jiangsu 213003, P.R. China.
Jun ZhangComprehensive Laboratory, Changzhou Key Laboratory of Individualized Diagnosis and Treatment Associated with High Technology Research, Changzhou, Jiangsu 213003, P.R. China.
Yanfei LiDepartment of Cardiothoracic Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213003, P.R. China.
Guanghua LuoComprehensive Laboratory, Changzhou Key Laboratory of Individualized Diagnosis and Treatment Associated with High Technology Research, Changzhou, Jiangsu 213003, P.R. China.
Xiaoying ZhangDepartment of Cardiothoracic Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213003, P.R. China.
Ning XuSection of Clinical Chemistry and Pharmacology, Institute of Laboratory Medicine, Lund University, SE‑221 85 Lund, Sweden.
Soochow University · CNLund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apolipoprotein M (apoM) may serve a protective role in the development of inflammation. Nuclear factor‑κB (NF‑κB) and its downstream factors (including a number of inflammatory cytokines and adhesion molecules) are essential for the regulation of inflammatory processes. In the present study, the importance of apoM in lipopolysaccharide (LPS)‑induced acute inflammation and its potential underlying mechanisms, were investigated using an apoM‑knockout mouse model. The levels of inducible nitric oxide synthase (iNOS), NF‑κB, interleukin (IL)‑1β, intercellular adhesion molecule 1 (ICAM‑1) and vascular cell adhesion protein 1 (VCAM‑1) were detected using reverse transcription‑quantitative PCR and western blotting. The serum levels of IL‑6 and IL‑10 were detected using Luminex technology. The results demonstrated that the protein levels of iNOS, NF‑κB, IL‑1β, ICAM‑1 and VCAM‑1 were significantly increased in apoM‑/‑ mice compared with those in apoM+/+ mice. In addition, two‑way ANOVA revealed that the interaction between apoM and LPS had a statistically significant effect on a number of factors, including the mRNA expression levels of hepatic iNOS, NF‑κB, IL‑1β, ICAM‑1 and VCAM‑1. Notably, the effects of apoM and 10 mg/kg LPS on the levels of IL‑6 and IL‑10 were the opposite of those induced by 5 mg/kg LPS, which could be associated with the dual anti‑ and pro‑inflammatory effects of IL‑6 and IL‑10. Collectively, the results of the present study revealed that apoM is an important regulator of inflammatory cytokine and adhesion molecule production in LPS‑induced inflammation, which may consequently be associated with the severity of inflammation. These findings indicated that the anti‑inflammatory effects of apoM may partly result from the inhibition of the NF‑κB pathway.

Indexed as

Up-RegulationAnimalsApolipoproteins MCell Adhesion MoleculesCytokinesGene Knockout TechniquesInflammationIntercellular Adhesion Molecule-1Interleukin-10Interleukin-1betaInterleukin-6LipopolysaccharidesMaleMiceNitric Oxide Synthase Type IIVascular Cell Adhesion Molecule-1Apolipoproteins MApoM protein, mouseCell Adhesion MoleculesCytokinesIcam1 protein, mouseIL10 protein, mouseIL1B protein, mouseIntercellular Adhesion Molecule-1Interleukin-10Interleukin-1betaInterleukin-6interleukin-6, mouseLipopolysaccharidesNitric Oxide Synthase Type IINos2 protein, mouseVascular Cell Adhesion Molecule-1

Identifiers

PMID32945469
PMCPMC7453663
OpenAlexW3048798909

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.